Preconditioning with levosimendan prevents contractile dysfunction due to H2O2-induced oxidative stress in human myocardium

Journal of Cardiovascular Pharmacology

Volumn 50, Issue 4, 2007, Pages 419-423

  Şahin, Ayşe Saide ^a   Görmüş, Niyazi ^a   Duman, Ateş ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Human myocardium; Levosimendan; Oxidative stress

Indexed keywords

HYDROGEN PEROXIDE; LEVOSIMENDAN;

ADULT; AGED; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; HEART ATRIUM; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INOTROPISM; MUSCLE ISOMETRIC CONTRACTION; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; ANTIOXIDANTS; ATRIAL APPENDAGE; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HUMANS; HYDRAZONES; HYDROGEN PEROXIDE; ISOMETRIC CONTRACTION; MIDDLE AGED; MYOCARDIAL CONTRACTION; OXIDATIVE STRESS; PYRIDAZINES;

EID: 37349102312     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318123fbf9     Document Type: Article

References (25)

1. Zimmermann N, Boknik P, Gams E, et al. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure? Eur J Cadiothoracic Surg. 1998;14:70-75.
2. Lochner A, Colesky F, Genade S. Effect of a calcium-sensitizing agent, levosimendan, on the postcardioplegic inotropic response of the myocardium. Cardiovasc Drugs Ther. 2000;14:271-281.
3. Garcia-Gonzalez MJ, Dominguez-Rodriguez A, Fere-Hita JJ. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: A series of cases. J Clin Pharmacol. 2005;45:704-708.
4. Nakamura K, Kusano K, Nakamura Y, et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation. 2002;105:2867-2871.
5. Abraham RB, Matza M, Marmor S, et al. Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress. Eur J Cardiothoracic Surg. 2003;23:66-73.
6. Konz KH, Haap M, Hill KE, et al. Diastolic dysfunction of perfused rat hearts induced by hydrogen peroxide. Protective effect of selenium. J Mol Cell Cardiol. 1989;21:789-795.
7. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB, et al. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol. 1998;125:1329-1335.
8. 2+-sensitizer levosimendan improves oxidative damage, BNP and proinflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. Eur J Heart Fail. 2005;7:882-887.
9. 2+ sensitizer levosimendan in human myocardium. Am J Physiol Heart Circ Physiol. 2002;282:H131-H137.
10. Usta C, Puddu PE, Papalia U, et al. Comparison of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae. J Cardiovasc Pharmacol. 2004;44:622-625.
11. 2+ channel blocker, on oxidative stres in cultured cardiac myocytes. Eur J Pharmacol. 1999;385:81-88.
12. 2-arachidonic acid signaling cascade in coronary artery smooth muscle. Am J Physiol Heart Circ Physiol. 2000;279:H475-H483.
13. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett. 2000;486:10-13.
14. Shimizu S, Saitoh Y, Yamamoto T, et al. Stimulation by hydrogen peroxide of L-arginine metabolism to L-citrulline coupled with nitric oxide synthesis in cultured endothelial cells. Res Commun Chem Pathol Pharmacol. 1994;84:315-329.
15. 2+]i in canine cerebral arterial smooth muscle: participation of cellular signaling pathways. Naunyn Schmiedebergs Arh Pharmacol. 1999;360:646-653.
16. Matsumura H, Hara A, Hashizume H, et al. Protective effects of ranolazine, a novel anti-ischemic drug, on the hydrogen peroxide-induced derangements in isolated, perfused rat heart: Comparison with dichloroacetate. Jpn J Pharmacol. 1998;77:31-39.
17. Jamali IN, Kersten JR, Pagel PS, et al. Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesth Analg. 1997;85:23-29.
18. 2+ sensitization predominantly enhances function and mechanical efficiency of stunned myocardium. Circulation. 1994;90:959-969.
19. Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19:660-668.
20. Lepran I, Pollesello P, Vajda S, et al. Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model. J Cardiovasc Pharmacol. 2006;48:148-152.
21. Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes. Am J Cardio. 2005;96:26G-31G.
22. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting - a pilot study. Br J Anaesth. 2006;96:694-700.
23. Metzsch C, Liao Q, Steen S, et al. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model. Acta Anaesthesiol Scand. 2007;51:86-93.
24. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res. 1992;70:223-233.
25. + channel in rat ventricular cells. J Pharmacol Exp Ther. 1997;283:375-383.